Developer docs
API playgroundTry for free, no card

Search company profiles

WEECO Pharma

Full company profile

uuid00396mq

Namestring
WEECO Pharma
Legal namestring
WEECO Pharma GmbH
Websiteurl
weeco.com
Company typeenum
Private
Founded yearint
2019
Descriptiontext

WEECO Pharma GmbH is a Hildesheim, Germany-based pharmaceutical wholesale company founded in 2019 and operating as a subsidiary of SYNBIOTIC SE (Nasdaq First North Denmark: STENNO). The company specializes in B2B distribution of medical cannabis — flowers, extracts, and compounded dosage forms — to pharmacies across Germany, Austria, and Switzerland under EU-GDP and EU-GMP compliance. Its product architecture combines bulk wholesale flower SKUs (10g and 1kg units, strains including Purple Rain, Frosted Lemon Angel, White Widow, Tavira 23/1, Hella Jelly 14/1) with higher-margin proprietary platforms: the ASTRUM SEDDS self-emulsifying drug delivery system for improved cannabinoid bioavailability (via Stenocare partnership), and the Rezeptur-Kompass modular compounding system enabling pharmacies to prepare patient-individual suppositories, transdermal creams, lozenges, capsules, and adjusted extracts. The company holds MedCan-Erlaubnis gem. §4 MedCanG, wholesale permit gem. §52a AMG, EU-GDP and EU-GMP certifications, with planned expansion to §72 AMG import and §13 AMG manufacturing permits.

Go-to-market is field-sales-led, with a nationwide sales team serving pharmacies directly, distribution through major channel partner Aurora Deutschland GmbH, and lead generation via ICBC Berlin and Expopharm trade shows. Revenue is generated through per-unit wholesale pricing on flowers and extracts, plus demand-side services such as GDP/GMP-compliant import-export logistics, pharmacy staff training, and rezeptur consultation. WEECO actively cultivates international sourcing partnerships (Portugal, North Macedonia, Denmark via Stenocare, California) and product co-development agreements (BOLDER Arzneimittel for cannabis lozenges) to differentiate on formulation and supply diversity rather than commodity pricing. The company's strategic positioning is reinforced by SYNBIOTIC SE's portfolio restructuring to focus capital on the medical cannabis platform (WEECO, MH medical hemp, SOLIDMIND), while WEECO itself maintains operational independence under Managing Directors Johannes Gallois, Börge Diessel, and Tony Schröter.

Short descriptiontext

WEECO Pharma is a Germany-based B2B pharmaceutical wholesaler founded in 2019 that distributes EU-GDP/GMP-certified medical cannabis flowers, proprietary SEDDS extracts, and pharmacy-compounded dosage forms to pharmacies across Germany, Austria, and Switzerland, operating as a subsidiary of SYNBIOTIC SE.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHildesheim, Germany
HQ citystring
Hildesheim
HQ countrystring
Germany
HQ regionstring
Europe
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical cannabis wholesale, pharmaceutical distribution, cannabis extracts, cannabinoid therapy, cannabis flowers
Industry1 code
PRIMARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)
NAICS code1 code
  • Drugs and Druggists' Sundries Merchant Wholesalers42421
SIC code1 code
  • Wholesale-Drugs, Proprietaries & Druggists' Sundries5122
Product category
Medical Cannabis Pharmaceutical Wholesale
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Cannabis Flower Wholesale
TypeOne Time License
Description

Wholesale distribution of medical cannabis flowers to pharmacies in Germany, Austria, and Switzerland. Products include various strains with defined THC and CBD content. Sales are B2B, requiring customer qualification and medical prescription.

weeco.com
2Cannabis Extracts Distribution
TypeOne Time License
Description

Distribution of EU-GMP compliant cannabis raw extracts and adjusted extracts (including WEECO ASTRUM products) for pharmaceutical compounding and direct patient use. Revenue generated through per-unit pricing.

weeco.com
3Compounding Base Materials
TypeOne Time License
Description

Supply of standardized galenic materials for pharmacy compounding including suppository bases, transdermal cream bases, lozenge components, and concentrated extracts for patient-specific formulations.

weeco.com
4GDP/GMP Compliant Import & Export Services
TypeProfessional Services
Description

International trade services for medical cannabis, facilitating imports to Germany from certified producers and exports to international markets. Services include regulatory compliance, quality assurance documentation, and accelerated export processes.

weeco.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Pricing details2 tiers
1Medical Cannabis Flowers - available in 10g and 1kg packaging units
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Products available in multiple package sizes including 10g retail units and 1kg bulk quantities. Specific strains include Purple Rain (24% THC), Frosted Lemon Angel (23% THC), White Widow (18% THC), and others. PZN numbers provided for German pharmacy ordering system.

weeco.com
2Compounded Cannabis Products - pharmacy compounding materials
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Maximum THC/CBD concentrations specified for different formulations: suppositories up to 100mg THC or CBD per unit, transdermal creams up to 100mg per pump, lozenges up to 75mg per 1g or 150mg per 2g, capsules up to 50mg per unit, adjusted extracts up to 250mg per ml.

weeco.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 3 records shown
1WEECO ASTRUM
Description

Cannabis extract product line using SEDDS technology for improved bioavailability, including WEECO ASTRUM 10-10 extract (10mg/ml THC and 10mg/ml CBD in 30ml bottle)

weeco.com
+2 more records
Core offering1 text field

WEECO Pharma GmbH is a pharmaceutical wholesaler that distributes EU-GMP and EU-GDP compliant medical cannabis flowers, raw extracts, and adjusted extracts (including the proprietary ASTRUM SEDDS-based extract line) to pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland. The portfolio is complemented by a modular Rezeptur-Kompass compounding system enabling pharmacies to produce patient-individual dosage forms such as lozenges, transdermal creams, suppositories, and capsules, along with related accessories like the O-Trap vaporizer.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • ASTRUM SEDDS technology improves bioavailability of cannabinoid active ingredients compared to conventional oil-based extracts
+1 more record
Product overview1 text field

WEECO Pharma is a pharmaceutical wholesale company specializing in medical cannabis and cannabinoid-based medicines, serving pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland since 2019. The product portfolio centers on wholesale distribution of EU-GMP and GDP-compliant cannabis flowers and extracts, complemented by an innovative galenic formulation system. The core offering includes various cannabis flower strains (Purple Rain, Frosted Lemon Angel, White Widow, Tavira 23/1, Hella Jelly 14/1) alongside the proprietary ASTRUM extract platform using SEDDS technology for improved bioavailability. A modular prescription system (Rezeptur-Kompass) enables pharmacies to prepare patient-individual dosage forms including lozenges, transdermal creams, suppositories, and capsules from standardized galenics. The company operates as a B2B partner exclusively supplying pharmacies and healthcare professionals.

Product and service15 records
1WEECO ASTRUM 10-10 Extrakt
CategoryMedical cannabis extract
Description

Cannabis oil extract containing 10mg/ml THC and 10mg/ml CBD in a 30ml bottle, based on patented ASTRUM SEDDS technology that improves bioavailability through a water-soluble, self-emulsifying carrier system. Distributed via partnership with Stenocare A/S to pharmacies in Germany.

2Cannabisextrakt-Lutschpastille
CategoryMedical cannabis lozenge
Description

THC-containing medicated lozenge for oral cannabinoid administration, developed as a patient-individual prescription product in collaboration with BOLDER Arzneimittel. Provides rapid, flavored dosing without social stigma for patients.

3Transdermale Cannabinoid-Cremes
CategoryCompounded cannabinoid formulation
Description

Transdermal cannabinoid creams enabling controlled active ingredient absorption through the skin, with up to 100mg THC or CBD per pump dose for local or systemic application. Compounded by pharmacies from WEECO base materials.

4Cannabinoid-Zäpfchen
CategoryCompounded cannabinoid formulation
Description

Cannabis suppositories for rectal or vaginal administration with consistent drug release and controllable dosing up to 100mg THC or CBD per unit. Suitable for patients with limited oral intake, bypassing the gastrointestinal tract.

5Cannabinoid-Kapseln
CategoryCompounded cannabinoid formulation
Description

Cannabis capsules for systemic therapy with reproducible active ingredient quantity, providing precise, patient-individual dosing up to 50mg THC or CBD per capsule for continuous medication.

6Eingestellter Cannabisextrakt
CategoryCannabis extract base material
Description

Adjusted cannabis extract serving as a base substance for numerous pharmacy formulations, with maximum concentration up to 250mg THC or CBD per ml, versatile for further processing into multiple dosage forms.

7PIEX2 Cannabisextrakt
CategoryCannabis extract raw material
Description

Highly concentrated pure cannabis extract with 70% THC content, free from fillers or carrier oils, supplied as a base substance for patient-individual pharmacy preparations including lozenges.

8WEECO Purple Rain
CategoryMedical cannabis flower
Description

Hybrid Sativa-dominant medical cannabis flowers with 24% THC and CBD under 1%, supplied in EU-GMP compliant pharmaceutical quality for pharmacy wholesale.

9WEECO Frosted Lemon Angel
CategoryMedical cannabis flower
Description

Hybrid medical cannabis flowers with 23% THC content in EU-GMP compliant pharmaceutical quality, supplied to pharmacies in 10g and 1kg packaging.

10WEECO White Widow
CategoryMedical cannabis flower
Description

Medical cannabis flowers with 18% THC content in EU-GMP compliant pharmaceutical quality, supplied to pharmacies.

11WEECO Tavira 23/1
CategoryMedical cannabis flower
Description

Medical cannabis flowers with indica-dominant genetics (Sour Punch) with up to 23% THC and CBD under 1%, produced in Portugal, E-beam irradiated, available in 250g and 1kg packaging.

12WEECO Hella Jelly 14/1 (WEECO MKD HJY 14/1)
CategoryMedical cannabis flower
Description

Sativa-dominant medical cannabis flowers with 14% THC and CBD under 1%, developed from Humboldt Seed Company genetics and cultivated in North Macedonia under organic Living Soil conditions.

13Medizinische Cannabisblüten (Sonstige Sorten)
CategoryMedical cannabis flower
Description

Various medical cannabis flower strains including THC-dominant, CBD-dominant, and balanced varieties, EU-GMP and GDP compliant, available in 10g and 1kg packaging for pharmacy wholesale supply.

14O-Trap
CategoryCannabis accessory device
Description

Vaporizer device for medical cannabis flower inhalation application, distributed alongside WEECO's cannabis flower portfolio for pharmacy patients.

15GDP/GMP-konformer Import und Distribution
CategoryPharmaceutical import/export services
Description

EU-GDP and EU-GMP compliant international trade services for medical cannabis, facilitating imports to Germany from certified producers and exports to international markets, including regulatory compliance, quality assurance documentation, and accelerated export processes.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Partnership5 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-01
Description

Strategic partnership for launching ASTRUM oil products in Germany. Stenocare, a Danish medical cannabis company listed on Nasdaq First North, provides EU-GMP certified cannabis oils based on their patented ASTRUM technology. WEECO Pharma leverages regulatory expertise and distribution network for German market entry. First product (WEECO ASTRUM 10-10 Extract with 10mg/ml THC and 10mg/ml CBD in 30ml bottles) launched February 2026.

Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2025-09-01
Description

Joint exhibition at Expopharm 2025 in Düsseldorf. Canymed, a cannabis company, co-exhibited with WEECO at Europe's largest pharmacy trade show to present new cannabis formulations including lozenges, transdermal creams, and WEECO ASTRUM products.

3BOLDER Arzneimittel GmbH & Co. KG
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-01
Description

Collaboration for development of medical cannabis lozenges (Lutschpastillen) - a first in the German market. BOLDER, a market leader in pharmaceutical lozenge manufacturing with over 100 years of experience and production of over 1 billion lozenges annually, developed the lozenge formulation. WEECO supplies the cannabis extract (PIEX2) base material with 70% THC content. Product launched Q2 2025.

weeco.com
4MH medical hemp GmbH
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-04-01
Description

Partnership within the SYNBIOTIC SE group for medical hemp products. MH medical hemp specializes in CBD extraction, production, and worldwide distribution of hemp-based cannabinoids. Supplies additional components for cannabis lozenge formulations alongside WEECO.

weeco.com
Strategic tierMajorTypeChannel Partner/ Reseller/ DistributorAnnounced on2024-06-01
Description

Aurora Deutschland GmbH, Germany's market leader in the medical cannabis flower segment, distributes WEECO products including the WEECO 25/1 medicinal cannabis flowers. Aurora is one of the leading importers, manufacturers, and wholesalers of medical cannabis in Germany.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Cannamedical is a Cologne-based medical cannabis wholesaler and importer supplying pharmacies across Germany with EU-GMP cannabis flowers and extracts, directly comparable to WEECO's core distribution business.

TypeEmerging player
Description

Canymed is a German cannabis company that co-exhibited with WEECO at Expopharm 2025 and develops new cannabis formulations including lozenges, transdermal creams, and extracts — overlapping with WEECO's compounding and extract portfolio.

TypeBroad incumbent
Description

Sanity Group is a broader European cannabis platform combining medical wholesale (via its subsidiary), cultivation, and consumer brands — operating at greater scale and broader scope than WEECO's medical-focused wholesale niche.

TypeDirect peer
Description

Four 20 Pharma is a German medical cannabis wholesaler distributing EU-GMP cannabis flowers and extracts to pharmacies — operating in the same regulated wholesale-to-pharmacy channel as WEECO.

TypeDirect peer
Description

Demecan is a German producer and wholesaler of medical cannabis flowers serving pharmacies under EU-GMP standards — directly overlapping with WEECO's core flower distribution and pharmacy wholesale business in Germany.

TypeDirect peer
Description

Fette Pharma is a German importer and wholesaler of medical cannabis and cannabinoid APIs, serving pharmacies and compounders under German pharmaceutical licensing — closely comparable to WEECO's wholesale and import operations.

TypeEmerging player
Description

Stenocare is a Danish medical cannabis producer and partner of WEECO for ASTRUM oil distribution in Germany; it operates as both a strategic partner and a competing EU-GMP producer in adjacent European markets.

TypeDirect peer
Description

Aurora Deutschland is described as Germany's market leader in medical cannabis flower wholesale and is simultaneously a WEECO distribution partner and a direct competitor in the same product category serving the same German pharmacy customers.

TypeDirect peer
Description

Nimbus Health is a German medical cannabis platform offering wholesale distribution plus a digital patient-pharmacy channel — overlapping with WEECO's wholesale model while adding a downstream telehealth layer WEECO does not operate.

10Tilray Brands
TypeBroad incumbent
Description

Tilray is a globally listed cannabis major with a German and European medical cannabis wholesale footprint — competing with WEECO in flower and extract distribution at much greater scale and broader geographic reach.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

WEECO Pharma

Medical Cannabis Pharmaceutical Wholesaleweeco.com

WEECO Pharma is a Germany-based B2B pharmaceutical wholesaler founded in 2019 that distributes EU-GDP/GMP-certified medical cannabis flowers, proprietary SEDDS extracts, and pharmacy-compounded dosage forms to pharmacies across Germany, Austria, and Switzerland, operating as a subsidiary of SYNBIOTIC SE.

What WEECO Pharma does

WEECO Pharma GmbH is a Hildesheim, Germany-based pharmaceutical wholesale company founded in 2019 and operating as a subsidiary of SYNBIOTIC SE (Nasdaq First North Denmark: STENNO). The company specializes in B2B distribution of medical cannabis — flowers, extracts, and compounded dosage forms — to pharmacies across Germany, Austria, and Switzerland under EU-GDP and EU-GMP compliance. Its product architecture combines bulk wholesale flower SKUs (10g and 1kg units, strains including Purple Rain, Frosted Lemon Angel, White Widow, Tavira 23/1, Hella Jelly 14/1) with higher-margin proprietary platforms: the ASTRUM SEDDS self-emulsifying drug delivery system for improved cannabinoid bioavailability (via Stenocare partnership), and the Rezeptur-Kompass modular compounding system enabling pharmacies to prepare patient-individual suppositories, transdermal creams, lozenges, capsules, and adjusted extracts. The company holds MedCan-Erlaubnis gem. §4 MedCanG, wholesale permit gem. §52a AMG, EU-GDP and EU-GMP certifications, with planned expansion to §72 AMG import and §13 AMG manufacturing permits.

Go-to-market is field-sales-led, with a nationwide sales team serving pharmacies directly, distribution through major channel partner Aurora Deutschland GmbH, and lead generation via ICBC Berlin and Expopharm trade shows. Revenue is generated through per-unit wholesale pricing on flowers and extracts, plus demand-side services such as GDP/GMP-compliant import-export logistics, pharmacy staff training, and rezeptur consultation. WEECO actively cultivates international sourcing partnerships (Portugal, North Macedonia, Denmark via Stenocare, California) and product co-development agreements (BOLDER Arzneimittel for cannabis lozenges) to differentiate on formulation and supply diversity rather than commodity pricing. The company's strategic positioning is reinforced by SYNBIOTIC SE's portfolio restructuring to focus capital on the medical cannabis platform (WEECO, MH medical hemp, SOLIDMIND), while WEECO itself maintains operational independence under Managing Directors Johannes Gallois, Börge Diessel, and Tony Schröter.

WEECO Pharma firmographics

Firmographics
Name
WEECO Pharma
Legal name
WEECO Pharma GmbH
Website
https://weeco.com
Company type
Private
Founded year
2019
Operating status
Operating
Headcount range
11–50 employees
Short description
WEECO Pharma is a Germany-based B2B pharmaceutical wholesaler founded in 2019 that distributes EU-GDP/GMP-certified medical cannabis flowers, proprietary SEDDS extracts, and pharmacy-compounded dosage forms to pharmacies across Germany, Austria, and Switzerland, operating as a subsidiary of SYNBIOTIC SE.
Ownership category
akta.pro rank

WEECO Pharma industry classification

Industry
Product category
Medical Cannabis Pharmaceutical Wholesale
NAICS
Drugs and Druggists' Sundries Merchant Wholesalers (42421)
SIC
Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
akta.pro industry
PRIMARYCRAOAHAG
Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience)

Keywords

  • Medical cannabis wholesale
  • Pharmaceutical distribution
  • Cannabis extracts
  • Cannabinoid therapy
  • Cannabis flowers

Where WEECO Pharma is headquartered

Location

Headquarters

HQ city
Hildesheim
HQ country
Germany
HQ region
Europe

Offices2 records

Markets served

WEECO Pharma business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales

Revenue model

  1. Cannabis Flower Wholesale: Wholesale distribution of medical cannabis flowers to pharmacies in Germany, Austria, and Switzerland. Products include various strains with defined THC and CBD content. Sales are B2B, requiring customer qualification and medical prescription.
  2. Cannabis Extracts Distribution: Distribution of EU-GMP compliant cannabis raw extracts and adjusted extracts (including WEECO ASTRUM products) for pharmaceutical compounding and direct patient use. Revenue generated through per-unit pricing.
  3. Compounding Base Materials: Supply of standardized galenic materials for pharmacy compounding including suppository bases, transdermal cream bases, lozenge components, and concentrated extracts for patient-specific formulations.
  4. GDP/GMP Compliant Import & Export Services: International trade services for medical cannabis, facilitating imports to Germany from certified producers and exports to international markets. Services include regulatory compliance, quality assurance documentation, and accelerated export processes.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goMedical Cannabis Flowers - available in 10g and 1kg packaging units
Unit PricingPay-as-you-goCompounded Cannabis Products - pharmacy compounding materials

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

WEECO Pharma product offering

Product offering

Core offering

WEECO Pharma GmbH is a pharmaceutical wholesaler that distributes EU-GMP and EU-GDP compliant medical cannabis flowers, raw extracts, and adjusted extracts (including the proprietary ASTRUM SEDDS-based extract line) to pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland. The portfolio is complemented by a modular Rezeptur-Kompass compounding system enabling pharmacies to produce patient-individual dosage forms such as lozenges, transdermal creams, suppositories, and capsules, along with related accessories like the O-Trap vaporizer.

Product overview

WEECO Pharma is a pharmaceutical wholesale company specializing in medical cannabis and cannabinoid-based medicines, serving pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland since 2019. The product portfolio centers on wholesale distribution of EU-GMP and GDP-compliant cannabis flowers and extracts, complemented by an innovative galenic formulation system. The core offering includes various cannabis flower strains (Purple Rain, Frosted Lemon Angel, White Widow, Tavira 23/1, Hella Jelly 14/1) alongside the proprietary ASTRUM extract platform using SEDDS technology for improved bioavailability. A modular prescription system (Rezeptur-Kompass) enables pharmacies to prepare patient-individual dosage forms including lozenges, transdermal creams, suppositories, and capsules from standardized galenics. The company operates as a B2B partner exclusively supplying pharmacies and healthcare professionals.

Differentiator

Problem solved

Functional benefit

Brands

  • WEECO ASTRUM: Cannabis extract product line using SEDDS technology for improved bioavailability, including WEECO ASTRUM 10-10 extract (10mg/ml THC and 10mg/ml CBD in 30ml bottle)
  • WEECO MKD HJY 14/1
  • WEECO Tavira 23/1

Products and services

  • WEECO ASTRUM 10-10 Extrakt Cannabis oil extract containing 10mg/ml THC and 10mg/ml CBD in a 30ml bottle, based on patented ASTRUM SEDDS technology that improves bioavailability through a water-soluble, self-emulsifying carrier system. Distributed via partnership with Stenocare A/S to pharmacies in Germany.
  • Cannabisextrakt-Lutschpastille THC-containing medicated lozenge for oral cannabinoid administration, developed as a patient-individual prescription product in collaboration with BOLDER Arzneimittel. Provides rapid, flavored dosing without social stigma for patients.
  • Transdermale Cannabinoid-Cremes Transdermal cannabinoid creams enabling controlled active ingredient absorption through the skin, with up to 100mg THC or CBD per pump dose for local or systemic application. Compounded by pharmacies from WEECO base materials.
  • Cannabinoid-Zäpfchen Cannabis suppositories for rectal or vaginal administration with consistent drug release and controllable dosing up to 100mg THC or CBD per unit. Suitable for patients with limited oral intake, bypassing the gastrointestinal tract.
  • Cannabinoid-Kapseln Cannabis capsules for systemic therapy with reproducible active ingredient quantity, providing precise, patient-individual dosing up to 50mg THC or CBD per capsule for continuous medication.
  • Eingestellter Cannabisextrakt Adjusted cannabis extract serving as a base substance for numerous pharmacy formulations, with maximum concentration up to 250mg THC or CBD per ml, versatile for further processing into multiple dosage forms.
  • PIEX2 Cannabisextrakt Highly concentrated pure cannabis extract with 70% THC content, free from fillers or carrier oils, supplied as a base substance for patient-individual pharmacy preparations including lozenges.
  • WEECO Purple Rain Hybrid Sativa-dominant medical cannabis flowers with 24% THC and CBD under 1%, supplied in EU-GMP compliant pharmaceutical quality for pharmacy wholesale.
  • WEECO Frosted Lemon Angel Hybrid medical cannabis flowers with 23% THC content in EU-GMP compliant pharmaceutical quality, supplied to pharmacies in 10g and 1kg packaging.
  • WEECO White Widow Medical cannabis flowers with 18% THC content in EU-GMP compliant pharmaceutical quality, supplied to pharmacies.
  • WEECO Tavira 23/1 Medical cannabis flowers with indica-dominant genetics (Sour Punch) with up to 23% THC and CBD under 1%, produced in Portugal, E-beam irradiated, available in 250g and 1kg packaging.
  • WEECO Hella Jelly 14/1 (WEECO MKD HJY 14/1) Sativa-dominant medical cannabis flowers with 14% THC and CBD under 1%, developed from Humboldt Seed Company genetics and cultivated in North Macedonia under organic Living Soil conditions.
  • Medizinische Cannabisblüten (Sonstige Sorten) Various medical cannabis flower strains including THC-dominant, CBD-dominant, and balanced varieties, EU-GMP and GDP compliant, available in 10g and 1kg packaging for pharmacy wholesale supply.
  • O-Trap Vaporizer device for medical cannabis flower inhalation application, distributed alongside WEECO's cannabis flower portfolio for pharmacy patients.
  • GDP/GMP-konformer Import und Distribution EU-GDP and EU-GMP compliant international trade services for medical cannabis, facilitating imports to Germany from certified producers and exports to international markets, including regulatory compliance, quality assurance documentation, and accelerated export processes.

Quantifiable outcome

  • ASTRUM SEDDS technology improves bioavailability of cannabinoid active ingredients compared to conventional oil-based extracts
  • +1 more outcomes

Companies that use WEECO Pharma

Customer profile

Named customers3 records

Segments3 records

Ideal customer profiles2 records

WEECO Pharma technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

WEECO Pharma partnerships and signals

Strategic signal

Partnerships

Five partnerships are on record, tiered core, minor and major.

  • Stenocare A/ScoreStrategic or Co-development Partner · 1 February 2026Strategic partnership for launching ASTRUM oil products in Germany. Stenocare, a Danish medical cannabis company listed on Nasdaq First North, provides EU-GMP certified cannabis oils based on their patented ASTRUM technology. WEECO Pharma leverages regulatory expertise and distribution network for German market entry. First product (WEECO ASTRUM 10-10 Extract with 10mg/ml THC and 10mg/ml CBD in 30ml bottles) launched February 2026.
  • Canymed (Grünhorn)minorGTM or Marketing Partner · 1 September 2025Joint exhibition at Expopharm 2025 in Düsseldorf. Canymed, a cannabis company, co-exhibited with WEECO at Europe's largest pharmacy trade show to present new cannabis formulations including lozenges, transdermal creams, and WEECO ASTRUM products.
  • BOLDER Arzneimittel GmbH & Co. KGcoreStrategic or Co-development Partner · 1 April 2025Collaboration for development of medical cannabis lozenges (Lutschpastillen) - a first in the German market. BOLDER, a market leader in pharmaceutical lozenge manufacturing with over 100 years of experience and production of over 1 billion lozenges annually, developed the lozenge formulation. WEECO supplies the cannabis extract (PIEX2) base material with 70% THC content. Product launched Q2 2025.
  • MH medical hemp GmbHcoreStrategic or Co-development Partner · 1 April 2025Partnership within the SYNBIOTIC SE group for medical hemp products. MH medical hemp specializes in CBD extraction, production, and worldwide distribution of hemp-based cannabinoids. Supplies additional components for cannabis lozenge formulations alongside WEECO.
  • Aurora Deutschland GmbHmajorChannel Partner/ Reseller/ Distributor · 1 June 2024Aurora Deutschland GmbH, Germany's market leader in the medical cannabis flower segment, distributes WEECO products including the WEECO 25/1 medicinal cannabis flowers. Aurora is one of the leading importers, manufacturers, and wholesalers of medical cannabis in Germany.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

WEECO Pharma competitors and assessment

Company assessment

Direct peers

  • Cannamedical Pharma GmbH: Cannamedical is a Cologne-based medical cannabis wholesaler and importer supplying pharmacies across Germany with EU-GMP cannabis flowers and extracts, directly comparable to WEECO's core distribution business.
  • Four 20 Pharma GmbH: Four 20 Pharma is a German medical cannabis wholesaler distributing EU-GMP cannabis flowers and extracts to pharmacies — operating in the same regulated wholesale-to-pharmacy channel as WEECO.
  • Demecan: Demecan is a German producer and wholesaler of medical cannabis flowers serving pharmacies under EU-GMP standards — directly overlapping with WEECO's core flower distribution and pharmacy wholesale business in Germany.
  • Fette Pharma GmbH: Fette Pharma is a German importer and wholesaler of medical cannabis and cannabinoid APIs, serving pharmacies and compounders under German pharmaceutical licensing — closely comparable to WEECO's wholesale and import operations.
  • Aurora Deutschland GmbH: Aurora Deutschland is described as Germany's market leader in medical cannabis flower wholesale and is simultaneously a WEECO distribution partner and a direct competitor in the same product category serving the same German pharmacy customers.
  • Nimbus Health GmbH: Nimbus Health is a German medical cannabis platform offering wholesale distribution plus a digital patient-pharmacy channel — overlapping with WEECO's wholesale model while adding a downstream telehealth layer WEECO does not operate.

Emerging players

  • Canymed (Grünhorn): Canymed is a German cannabis company that co-exhibited with WEECO at Expopharm 2025 and develops new cannabis formulations including lozenges, transdermal creams, and extracts — overlapping with WEECO's compounding and extract portfolio.
  • Stenocare A/S: Stenocare is a Danish medical cannabis producer and partner of WEECO for ASTRUM oil distribution in Germany; it operates as both a strategic partner and a competing EU-GMP producer in adjacent European markets.

Broad incumbents

  • Sanity Group GmbH: Sanity Group is a broader European cannabis platform combining medical wholesale (via its subsidiary), cultivation, and consumer brands — operating at greater scale and broader scope than WEECO's medical-focused wholesale niche.
  • Tilray Brands: Tilray is a globally listed cannabis major with a German and European medical cannabis wholesale footprint — competing with WEECO in flower and extract distribution at much greater scale and broader geographic reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

WEECO Pharma social profiles

Digital presence

WEECO Pharma compliance and trust

Trust signal

Compliance7 records

WEECO Pharma financial estimates

Financial estimate

Revenue estimate

Valuation estimate

WEECO Pharma leadership team

Management profile

Number of profiles

Profiles4 records

WEECO Pharma funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

WEECO Pharma M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about WEECO Pharma

What does WEECO Pharma do?

WEECO Pharma GmbH is a pharmaceutical wholesaler that distributes EU-GMP and EU-GDP compliant medical cannabis flowers, raw extracts, and adjusted extracts (including the proprietary ASTRUM SEDDS-based extract line) to pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland. The portfolio is complemented by a modular Rezeptur-Kompass compounding system enabling pharmacies to produce patient-individual dosage forms such as lozenges, transdermal creams, suppositories, and capsules, along with related accessories like the O-Trap vaporizer.

Is WEECO Pharma a public or private company?

WEECO Pharma is a private company. It is classified as corporate owned and is currently operating.

When was WEECO Pharma founded?

WEECO Pharma was founded in 2019. It employs 11 to 50 people.

Where is WEECO Pharma based?

WEECO Pharma is headquartered in Hildesheim, Germany, in the Europe region.

How does WEECO Pharma make money?

Four revenue lines are on record. Cannabis Flower Wholesale is the primary driver. The others are cannabis Extracts Distribution, compounding Base Materials and GDP/GMP Compliant Import & Export Services.

Who are WEECO Pharma's main competitors?

Direct peers on record are Cannamedical Pharma GmbH, Four 20 Pharma GmbH, Demecan, Fette Pharma GmbH, Aurora Deutschland GmbH and Nimbus Health GmbH. Emerging players are Canymed (Grünhorn) and Stenocare A/S. Broad incumbents are Sanity Group GmbH and Tilray Brands.

Does WEECO Pharma have an API?

No public API is recorded for WEECO Pharma.

What industry is WEECO Pharma in?

WEECO Pharma's product category is Medical Cannabis Pharmaceutical Wholesale. Its primary akta.pro industry code is CRAOAHAG, Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience). Its NAICS code is 42421 and its SIC code is 5122.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
news.cision.comInterim report fourth quarter and Financial Statement Release 2025STENOCARE A/S released its Q4 and full-year 2025 financial results, reporting net sales of 7,021 KDKK for the full year and achieving three consecutive quarters of positive EBITDA with Q4 EBITDA of 12 KDKK. The company completed the acquisition of CannGros ApS in November 2025, adding an estimated DKK 4-6 million in annual revenue, and subsequently announced strategic partnerships with WEECO Pharma for product launch in Germany and a distribution partnership in France. Sales for Q4 2025 grew 36% over Q3 2025 and 107% compared to Q4 2024, while personnel expenses decreased 37% year-over-year.PharmiWeb.comIRIS Capital invests in SYNBIOTIC's growth strategyIRIS Capital Investment and SYNBIOTIC SE entered a strategic partnership, with IRIS committing up to EUR 2.4 million in non-interest-bearing convertible bonds. SYNBIOTIC's subsidiary WEECO Pharma exceeded its 2024 sales target, prompting upward adjustments to 2025-2027 sales plans.PharmiWeb.comIn full bloom: WEECO Pharma boosts SYNBIOTIC's salesWEECO Pharma, acquired by SYNBIOTIC, exceeded its 2024 revenue target, reaching EUR 6.75 million by October 2024. Full-year 2024 revenue is expected to exceed EUR 8 million, prompting upward adjustments to 2025-2026 sales plans. SYNBIOTIC plans further acquisitions in cultivation and supply chain.SynbioticIn full bloom: WEECO Pharma boosts SYNBIOTIC's salesWEECO Pharma, acquired by SYNBIOTIC, exceeded its 2024 revenue target, reaching EUR 6.75 million as of October 2024. Full-year 2024 revenue is expected to exceed EUR 8 million, prompting upward adjustments to 2025 and 2026 sales plans. SYNBIOTIC plans further acquisitions in cultivation and supply chain.